Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond R Tubbs

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
JAMA|October 21, 2004
HER-2 testing in breast cancerRaymond R Tubbs, David G Hicks
Journal of Molecular Histology|April 12, 2007
Tissue microarrays: robust molecular morphology toolsLawrence E DeBault, Raymond R Tubbs
The Journal of Molecular Diagnostics : JMD|June 25, 2013
New guideline sets the ground rules for routine molecular testing in non-small cell lung cancerNathan A Pennell, Raymond R Tubbs
Human Pathology|March 26, 2005
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelinesDavid G Hicks, Raymond R Tubbs
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|October 22, 2008
Mutations in myeloid neoplasmsClaudiu V Cotta, Raymond R Tubbs
Plos One|August 26, 2014
Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplificationZsuzsanna Varga, Raymond R Tubbs, Holger Moch
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 2, 2005
Molecular genetic testing of polymorphisms associated with venous thrombosis: a review of molecular technologiesBo Xu, Raymond R Tubbs, Kandice Kottke-Marchant
Journal of Clinical Pathology|March 6, 2010
Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaAaron M Gruver, Ziad Peerwani, Raymond R Tubbs
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2002
Demonstration of immune complex deposits using fluorescence microscopy of hematoxylin and eosin-stained sections of Hollande's fixed renal biopsiesJames T McMahon, Jonathan L Myles, Raymond R Tubbs
Archives of Pathology & Laboratory Medicine|April 30, 2011
Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classificationAaron M Gruver, Bryce P Portier, Raymond R Tubbs
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
JAMA|October 21, 2004
HER-2 testing in breast cancerRaymond R Tubbs, David G Hicks
Journal of Molecular Histology|April 12, 2007
Tissue microarrays: robust molecular morphology toolsLawrence E DeBault, Raymond R Tubbs
The Journal of Molecular Diagnostics : JMD|June 25, 2013
New guideline sets the ground rules for routine molecular testing in non-small cell lung cancerNathan A Pennell, Raymond R Tubbs
Human Pathology|March 26, 2005
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelinesDavid G Hicks, Raymond R Tubbs
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|October 22, 2008
Mutations in myeloid neoplasmsClaudiu V Cotta, Raymond R Tubbs
Plos One|August 26, 2014
Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplificationZsuzsanna Varga, Raymond R Tubbs, Holger Moch
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 2, 2005
Molecular genetic testing of polymorphisms associated with venous thrombosis: a review of molecular technologiesBo Xu, Raymond R Tubbs, Kandice Kottke-Marchant
Journal of Clinical Pathology|March 6, 2010
Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaAaron M Gruver, Ziad Peerwani, Raymond R Tubbs
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2002
Demonstration of immune complex deposits using fluorescence microscopy of hematoxylin and eosin-stained sections of Hollande's fixed renal biopsiesJames T McMahon, Jonathan L Myles, Raymond R Tubbs
Archives of Pathology & Laboratory Medicine|April 30, 2011
Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classificationAaron M Gruver, Bryce P Portier, Raymond R Tubbs
Pageof 13